Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 107
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Inceptor binds to and directs insulin towards lysosomal degradation in β cells

Inceptor binds to and directs insulin towards lysosomal...

 153

Advanced multiparametric image spectroscopy and super-resolution microscopy reveal a minimal model of CD95 signal initiation

Advanced multiparametric image spectroscopy and super-r...

 111

Comprehensive dissection of rectal cancer organoids in responses to chemoradiation

Comprehensive dissection of rectal cancer organoids in ...

 57